Research Topics
| Alexandra M LevineSummaryAffiliation: City of Hope National Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine
City of Hope National Medical Center, Duarte, CA 91010, USA
J Clin Oncol 31:58-64. 2013....
Lymphomas and leukemias due to infectious organismsAlexandra M Levine
City of Hope National Medical Center, Duarte, CA, USA
Hematology 17:S87-9. 2012..The presentation will focus on the latter three disorders, describing pathogenesis of disease, clinical manifestations and therapeutic options...- HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV StudyAlexandra M Levine
City of Hope National Medical Center, Duarte, CA 91010, USA
J Clin Oncol 28:1514-9. 2010..We sought to determine the role of HIV infection and highly active antiretroviral therapy (HAART) on lung cancer incidence in 2,651 HIV-infected and 898 HIV-uninfected women from the Women's Interagency HIV Study (WIHS)... - Management of AIDS-related lymphomaAlexandra M Levine
City of Hope National Medical Center, Duarte, CA 91011, USA
Curr Opin Oncol 20:522-8. 2008..Paradigms of therapy have changed. Although the incidence of AIDS-lymphoma has decreased, the incidence of HIV-associated Hodgkin's lymphoma has increased; mechanisms for these changes in epidemiology will be discussed... 
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapySoon Thye Lim
Norris Comprehensive Cancer Center, Los Angeles, CA, USA
J Clin Oncol 23:4430-8. 2005..The current practice of using the same regimen for both groups of patients should be re-evaluated...- Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphomaAnil Tulpule
Division of Hematology, Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
Clin Lymphoma Myeloma 7:59-64. 2006..Liposomal doxorubicin at doses of 40 mg/m2, 50 mg/m2, 60 mg/m2, and 80 mg/m2 was given with fixed doses of cyclophosphamide, vincristine, and prednisone. Chemotherapy cycles were repeated every 21 days... - Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of responseAlexandra M Levine
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
J Clin Oncol 22:2662-70. 2004..Secondary objectives were to assess the impact of HIV viral control on response and survival, and to correlate MDR-1 expression with outcome... - Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule
Department of Medicine and Radiology, University of Southern California Medical Center, Norris Cancer Hospital and Research Institute, Los Angeles, CA, USA
Invest New Drugs 22:63-8. 2004..To evaluate the response and side effects of combination therapy with low dose CHOP chemotherapy and mitoguazone dihydrochloride in patients with non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome (AIDS-NHL)... - Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patientsAlexandra M Levine
City of Hope National Medical Center, 1500 Duarte Road, Duarte, California 91010, USA
AIDS Res Hum Retroviruses 24:131-9. 2008.... - Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapySoon-Thye Lim
Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
J Clin Oncol 23:8477-82. 2005..CONCLUSION: Prognostic factors and overall survival of patients with HIV-DLCC have changed. Clinical outcomes in patients with HIV-DLCL are now approaching the outcomes of patients with de novo lymphoma... - Multidrug resistance (MDR-1) expression in AIDS-related lymphomasAnil Tulpule
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Leuk Res 26:121-7. 2002..9 months, P=0.003). Strategies to overcome MDR-1 expression may be important for initial treatment in patients with AIDS-NHL... - Anemia in HIV infection: clinical impact and evidence-based management strategiesPaul A Volberding
University of California, San Francisco, CA, USA
Clin Infect Dis 38:1454-63. 2004.... - Malignancies in women with HIV infectionAmrita Krishnan
City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA
Womens Health (Lond Engl) 4:357-68. 2008..The use of therapy has been associated with marked improvement in response rates and overall survival of affected patients... - Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infectionMaria C Villacres
Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
J Infect Dis 206:780-9. 2012..We investigated the correlation of cytokine responses with changes in CD4 T-cell levels and coinfection with hepatitis C virus (HCV) during highly active antiretroviral treatment (HAART)... - Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphomaSoon Thye Lim
University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA, USA
CA Cancer J Clin 55:229-41; 260-1, 264. 2005.... - The treatment of AIDS-related cancersAlexandra M Levine
USC/Norris Cancer Hospital, CA, USA
Lancet Oncol 4:576-81. 2003